Virginia Eye Consultants (J.S.), Norfolk, VA; Kannarr Eye Care (S.K.), Pittsburg, KS; Florida Vision Institute (J.L.), West Palm Beach, FL; Ophthalmology Associates (R.M.), St. Louis, MO; Sun Pharmaceutical Industries, Inc. (A.J., A.O.), Princeton, NJ; Sun Pharma Advanced Research Company Ltd (C.D.), Princeton, NJ; and North Bay Eye Associates (J.B.), Petaluma, CA.
Address correspondence to John Sheppard, M.D., Virginia Eye Consultants, 241 Corporate Boulevard, Norfolk, VA 23502; e-mail: [email protected]
J. Sheppard reports personal fees from Allergan, Alcon/Novartis, Avedro, Bausch & Lomb, Clementia Pharma, Ocular Therapeutix, Science Based Health, Senju, Shire, Sun Pharmaceuticals Industries, Inc., TearLab, TearScience, Topcon, and Topivert, and other fees from Alcon/Novartis, Kala Pharmaceuticals, Novaliq, Noveome, Ocular Therapeutix, Shire, and TearLab. S. Kannarr reports personal fees from Allergan, Alcon, Bausch & Lomb, Essilor, Johnson & Johnson, Oculos, Optovue, and Trial Runners. J. Luchs reports personal fees from Allergan, Alcon, Bausch & Lomb, Shire, Sun Pharmaceutical Industries, Inc., and TearLab, and other fees from Allergan, Alcon, Bausch & Lomb, Calhoun Vision, CLXO, Insightful Solutions, Shire, Sun Pharmaceutical Industries, Inc., and Trefoil Therapeutics. R. Malhotra reports consultant fees from Abbott Laboratories, Alcon, Allergan, Bausch & Lomb, BioD, InSite Vision, Katena Products, Nicox, OASIS Medical, Shire, and TearScience, and speaker and other fees from Abbott Laboratories, Alcon, Allergan, Bausch & Lomb, BioD, InSite Vision, Katena Products, Nicox, OASIS Medical, Shire, and TearScience. A. Justice was an employee of Sun Pharmaceutical Industries, Inc., at the time of manuscript preparation and is currently an employee of Aerie Pharmaceuticals. A. Ogundele is an employee of Sun Pharmaceutical Industries, Inc. C. Darby is a contracted consultant of Sun Pharma Advanced Research Company, Ltd. J. Bacharach reports speaker fees from Aerie, Alcon, Allergan, Bausch & Lomb, Glaukos, New World Medical, and Sun Pharmaceutical Industries, Inc., and consultant fees from Aerie, Alcon, Allergan, Bausch & Lomb, Optovue, Injectsense, and New World Medical.
This study was sponsored and funded by Ocular Technologies, SARL (now a wholly owned subsidiary of Sun Pharmaceutical Industries, Inc.). Ocular Technologies, SARL, participated in the design, conduct, monitoring, data collection, data management, and data analysis of the study. Writing and editorial support for manuscript preparation were provided by Ginny Feltzin, PhD, of AlphaBioCom, LLC, and funded by Sun Pharmaceutical Industries, Inc. All authors met the International Council of Medical Journal Editors criteria and received neither honoraria nor payment for authorship.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.eyeandcontactlensjournal.com).
